Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological E's jab Corbevax and anti-Covid pill...
1.png "Modi, Mamata Both Figure On TIME List Of '100 Most Influential People' Of 2021")
The political rivals rub shoulders with world ‘Leaders’: Joe Biden, Kamala Harris, Donald Trump, Abdul Ghani Baradar. Adar Poonawal figures on the list of ‘Pioneers’.
.png "Record Indians get their admissions to UK universities in 2021. (Representational image)")
This year’s admission of Indian students to UK Universities, marks an overall increase of 19 percent in comparison to the previous year.
Poonawalla Fincorp stated that the transaction would result in a pre-tax profit of Rs 351.85 crore. Additionally, increase its capital adequacy ratio from the existing 52.2 per cent to 56.1 per cent.
The efficacy of this approach has not been proven in field trials involving thousands of participants, Cyrus Poonawalla said
Santosh K More has raised the issue in a tweet tagging PM Modi and Serum Institute CEO Adar Poonawalla
.png "Adar Poonawalla, CEO of Serum Institute. (File photo)")
The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccine doses in November this year.
While Covishield has an emergency use listing from the WHO, it is yet to receive a similar approval from the European Union.
Serum Institute of India’s Covishield has not received the EU Covid-19 Vaccination Passport due to which those vaccinated with Covishield will not be able to...
The travellers vaccinated with Covishield may not be eligible for the European Union ‘Green Pass’- an immunity document that is meant to ease travel
Taking to Twitter, SII CEO said, 'Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune.'
In a letter to the Union Health Ministry on May 22, Serum Institute clarified that the statement by its executive director Suresh Jadav at a recent event is...
.png)
Serum continues to scale up manufacturing and prioritise India. It also hopes to start delivering (vaccines) to COVAX and other countries by end of this year,...
As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share, taking the total deal value to Rs 118.02...
'We’ve not received the vaccines yet, we are in constant touch with the company. We are hopeful that vaccines will reach by tomorrow or the day after,' Delhi...
Making the announcement, Union government officials said the aim of the move was to protect the Pune-based businessman from 'potential threats'
Serum Institute of India (SII) in a statement clarified that there was an 'inaccurate comparison' done between the global prices of the vaccine with India.
This comes ahead of the new round of vaccinations from May 1 that will include all above 18.
The production of at least 160 million doses of Covid-19 vaccines (per month) may come to a halt in the coming weeks if the US doesn’t provide 37 critical...
'We are going to have to keep supplying to India, and not anywhere else. Because we have to protect our nation', said Serum Institute of India's CEO Adar...
.jpg)
Clinical trials for covid-19 vaccine ‘Covovax’ have begun in India and Serum Institute hopes to launch it by September, SII CEO Adar Poonawalla said.
NGOs such as Medecins Sans Frontieres have alleged that the move would lead to a Covid-19 vaccine crunch in many developing countries.
Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, Adar Poonawalla...
Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said his company has applied to start the trials of another COVID-19 vaccine
The fire broke out on Thursday afternoon in a complex that is under construction and a few minutes' drive from the facility where the Covid vaccines are...
